Deciphera Pharmaceuticals
在场
Deciphera Pharmaceuticals 的所有者是 ONO Pharmaceutical.
是其中之一......
ONO Pharmaceutical 是一家在股票代码 4528 (JP) 下上市的公司。
ONO Pharmaceutical 在 2 个国家有直接业务。
涉及ONO Pharmaceutical的并购和融资。
高管
查看带有其 14 名主要高管的组织结构图
Deciphera Pharmaceuticals 搜索最多的简介
- Steven Hoerter, Director, President and Chief Executive Officer
- Masayuki Tanigawa, Director
- Toichi Takino, Director
高管在Deciphera Pharmaceuticals变化
- Masayuki Tanigawa已作为Director加入公司 (新闻发布的2024六月12号).
- Ron Squarer, Director, 已经离开公司 (新闻发布的2024六月12号).
- James Bristol, Chairman of the Board, 已经离开公司 (新闻发布的2024六月12号).
创建提醒
跟踪 Deciphera Pharmaceuticals 的高管变动
药店
ONO Pharmaceutical 拥有 1,841 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
- BeiGene将改名为BeOne Medicines。 (公布2024十一月15号).
- GlycoMimetics and Crescent Biopharma have announced they will merge (公布2024十一月15号)..
药店 行业的其他推荐联系人
消息
Deciphera Pharmaceuticals 的最新新闻稿
- Deciphera Pharmaceuticals, Inc. Announces Second Quarter 2022 Financial Results | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. to Announce Second Quarter 2022 Financial Results and Host Conference Call and Webcast on August 4, 2022 | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. Appoints Kelley Dealhoy as Chief Business Officer | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. to Participate in Upcoming Investor Conferences | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. Announces First Quarter 2022 Financial Results | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals to Announce First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 4, 2022 | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals Announces Closing of Public Offering of Common Stock and Pre-funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Pre-funded Warrants | Deciphera Pharmaceuticals, Inc.
- View more press releases Close
通过电子邮件
